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Pietro Amedeo Modestia,b, Antonella Ferraria, Cristina Bazzinia,
Giusi Costanzoa, Ignazio Simonettia, Stefano Taddeic, Annibale Biggerid,
Gianfranco Paratie,f, Gian Franco Gensinia,b and Saulo SirigatticBackground The possibility that daily sessions of music-
guided slow breathing may reduce 24-h ambulatory blood
pressure (ABP), and predictors of efficacy were explored in
a randomized, placebo-controlled trial with parallel design.
Methods Age-matched and sex-matched hypertensive
patients were randomized to music-guided slow breathing
exercises (4–6breaths/min; 1 : 2 ratio of
inspiration : expiration duration) (Intervention; nU29) or to
control groups who were thought to relax while either
listening to slow music (Control-M; nU26) or reading a
book (Control-R; nU31). At baseline and at follow-up visits
(1 week and 1, 3 and 6 months), ABP monitoring was
performed.
Results At mixed model analysis, intervention was
associated with a significant reduction of 24-h (PU0.001)
and night-time (0100–0600h) (P<0.0001) systolic ABP.
The average reduction of systolic 24-h ABP at 6 months was
4.6mmHg [confidence limits at 95% 1.93–7.35] and
4.1mmHg (95% confidence limits 1.59–6.67) vs. Control-M
and Control-R groups, respectively, (P<0.001 for both).
Antihypertensive treatment was selected as negative
predictor of BP reduction at multivariate stepwise analysis.
When antihypertensive treatment was inserted as covariate
in a generalized linear model, psychological subscales
assessed at baseline by the Mental Health Inventory
questionnaire were found to affect systolic blood pressure
reduction at 6-month follow-up (general positive affect
P<0.001; emotional ties, P<0.001; loss of behavioralopyright © Lippincott Williams & Wilkins. Unauth
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affect higher than the 75th percentiles was found to be
significantly associated with low treatment efficacy (odds
ratio 0.09; 95% confidence limits 0.01–0.93).
Conclusion Daily sessions of voluntary music-guided slow
breathing significantly reduce 24-h systolic ABP, and
psychological predictors of efficacy can be identified.
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Different behavioral techniques (yoga or meditation
practice) were reported to reduce blood pressure (BP)
and antihypertensive drug requirements [1–3], although
conflicting results exist [4]. Methodological shortcomings
[5] may have limited some of these studies, which,
however, cannot be considered as a whole because of
the relevant differences in tasks or stimuli used. These
differences make impossible to identify the factor(s)
responsible for antihypertensive effect, so in recent yearsdevices were developed to focus specially on breathing
rate [6–9]. Electronic devices capable of driving the
breathing rate by means of sounds were thus used in
clinical studies performed with a preobservational and
postobservational design [10,11], with a design similar to
that of prospective matched case–control studies [12,13]
and randomized controlled trials [14,15], all providing
evidence in favor of a reduction of office and home BP
after 2 months of daily sessions of slow-breathing exer-
cises below 10 breaths/min. With these supports [16,17],
device-guided slow breathing is now approved for use as
an adjunct to lifestyle modifications and drug therapy in
hypertensive patients. However, no information exists
regarding predictors of success and compliance. Toorized reproduction of this article is prohibited.
DOI:10.1097/HJH.0b013e3283362762
C1098 Journal of Hypertension 2010, Vol 28 No 5define which patients may really benefit from behavioral
methods would be of great value to move this demanding
nonpharmacologic treatment into the clinical practice.
An acute reduction in breathing rate and BP was also
observed during listening to music with slow rhythm and
tempo [18,19], and a possible entrainment of respiration
rate to tempo (i.e. temporal patterning conveyed by
tones’ perception) was reported [8,19]. However, no
studies investigated the antihypertensive effects of slow
music listening and the relative contribution of specific
voluntary breathing exercises.
Therefore, a randomized, placebo-controlled study with
parallel design was performed to investigate, in hyper-
tensive patients, the effect of voluntary music-guided
breathing exercises on ambulatory BP and possible pre-
dictors of efficacy [20] and compliance.
Patients and methods
Participants
The study protocol was approved by the local ethics
committee (Prot.n.2009/0004365), and all participants
gave informed consent to participate in the study.
Inclusion criteria were outpatients aged 40–75 years with
essential hypertension, untreated or constantly treated
with the same doses of antihypertensive drugs for at least
3 months prior to the study. Exclusion criteria were
chronic atrial fibrillation, angina, heart failure, cerebro-
vascular disease, diabetes mellitus, renal failure, asthma,
chronic respiratory disease, pregnancy, neoplasia and
altered night-time sleep because of shift work. Clinical
characteristics of participants at enrolment are reported
in Table 1. None of them had received formal musical
training.
Study design and protocol
The study had a randomized, placebo-controlled, parallel
design. The presumed role of stress in hypertension was
preliminarily explained to all eligible participants, andopyright © Lippincott Williams & Wilkins. Unautho
Table 1 Characteristics of individuals at enrolment
Variables Control-R (reading) Control-M
Male/female (n/n) 20/11 16/
Age (years) 61 (56–65) 58 (53
Smokers (n) 1 1
BMI (kg/m2) 26 (24–27) 25 (23
Waist circumference (cm) 94 (89–99) 93 (82
Systolic BP (mmHg) 130 (125–134) 131 (12
Diastolic BP (mmHg) 77 (73–81) 79 (75
Heart rate (bpm) 70 (65–74) 72 (67
Blood glucose (mg/dl) 94 (88–101) 93 (85
Total cholesterol (mg/dl) 197 (184–209) 201 (18
HDL cholesterol (mg/dl) 57 (53–61) 60 (49
LDL cholesterol (mg/dl) 115 (104–125) 117 (94
Triglycerides (mg/dl) 102 (87–118) 98 (75
Uric acid (mg/dl) 5.4 (4.8–5.9) 5.6 (4.1
Creatinine (mg/dl) 0.88 (0.80–0.95) 0.85 (0.7
Creatinine clearance (ml/min) 87 (79–96) 88 (70
Mean (95% confidence limits). ANOVA, univariate analyses of variance; BP, blood prthey were told that the study was designed to compare
the effects of different approaches of relaxation therapy.
If participants agreed, they were randomized into three
groups. Participants allocated into the intervention group
(n¼ 29) were thought to perform the Buteyko and pra-
nayama breathing technique (see following section) with
breathing rate guided by music excerpts characterized by
slow rhythm and tempo [19] (see the list at end of this
paragraph). Participants allocated to control groups
received no mention of breathing exercises and were
thought to relax while either listening to slow music
(see the list) (Control-M group; n¼ 26) or reading a book
or magazine (Control-R group; n¼ 31). All participants
were requested to repeat daily, at home for 6 months, the
30-min relaxation session at least 3 h after lunch. Follow-
up visits were scheduled at 1 week, 1, 3 and 6 months. A
further follow-up visit 6 months after the end of treat-
ment was scheduled for the intervention group.
The excerpts of the classical music repertoire used
included(1) Mriz
(mus
10
–61)
–26)
–103
5–13
–82)
–77)
–101
1–22
–71)
–140
–121
–7.1)
4–0.9
–106
essurozart WA: Violin Concerto No. 3 in G major–II
(Adagio)(2) Mozart WA: Clarinet Concerto in A major II (Adagio)
(3) Mozart WA: Piano Concerto No. 23 in A major–II
(Adagio)
(4) Mozart WA: Piano Concerto No. 21 in C Major–II
(Andante)
(5) Bach JS: Air from Suite No. 3 in D (transcribed for
cello and piano by L. Rose)
(6) Rachmaninov S: Vocalise, Op. 34, No.14 (transcribed
for cello and piano by L. Rose)The pieces of Celtic inspired music included four songs
for harp and female voice:(1) Garella D: ‘Paesaggio d’Autunno’
(2) Garella D: ‘Canto nel Vento’
(3) Schroeder T: ‘Mana Vu’
(4) McKennitt L: ‘Prospero’s Speech’ed reproduction of this article is prohibited.
ic) Intervention (musicþ respiration) ANOVA (P)
16/13 0.594
58 (54–62) 0.406
2 0.796
25 (24–27) 0.744
) 94 (88–99) 0.972
5) 131 (126–136) 0.876
79 (74–83) 0.827
72 (67–77) 0.640
) 95 (87–103) 0.944
1) 203 (186–219) 0.819
59 (52–66) 0.768
) 118 (100–136) 0.943
) 100 (82–117) 0.936
5.5 (4.7–6.2) 0.925
6) 0.87 (0.79–0.96) 0.898
) 90 (78–102) 0.927
e; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
CBehavioral treatment and 24-h ABP Modesti et al. 1099The Indian Raga music used included(1) Sophantam: ‘Heart rain’ (composed on the Raga Megh
scale – flauto bansuri and tampura)(2) Tapasya: ‘Raga Bhairav’ (Shiva mantra and tampura).Care was taken that participants from the different groups
did not meet or acquire extracurricular relaxation skills.
At follow-up visits, all participants were seen individually
by the same assistant who inquired about stressful
periods and the influence of the daily rest on their general
well-being. Participants kept diary cards to record home
sessions and medication use. Quality of life (QoL) was
assessed at randomization and at the 6-month follow-up
visit using the Medical Outcome Study Short-form
36-Item Health Survey [21]. Participants allocated to
the voluntary music-guided breathing exercises were
requested to fill the Mental Health Inventory question-
naire (MHI) [20] at randomization. Psychological sub-
scales (anxiety, depression, loss of behavioral and
emotional control, general positive affect, emotional ties,
satisfaction of life) were then calculated.
Training and intervention
Breathing technique was taught by a certified practitioner
in a single 2-h session. After 20 min of quiet rest, listening
of music characterized by homogeneous regular and slow
rhythm and tempo (52 bits/min, Metronome Marking)
(range: 40–60) (see the list in the previous section) [19]
was started. During the first 10 min the patient was
requested to synchronize his respiration to the slow
musical rhythm, reaching 4–6 breaths/min (Buteyko
method) [22], and then to maintain the same rate while
performing ‘abdominal’ breathing with a 1 : 2 inspiration :
expiration duration ratio (pranayama yoga) [22] for the
other 20 min. The session with the therapist was repeated
after 1 week, 1, 3 and 6 months from allocation.
Blood pressure measurements
Office BP measurements were taken at each visit (base-
line and follow-up visits) with a validated instrument
(M6, OMRON HEALTHCARE Co., Ltd., Kyoto, Japan)
[23]. At each visit, 24-h ambulatory BP monitoring was
also performed with a validated device (SpaceLabs
90207; Spacelabs Healthcare Co., Issaquah, Washington,
USA) [24] programmed to take measurements at 15 and
20-min intervals over the day and the night, respectively
[25]. No data editing was performed, and systolic and
diastolic ambulatory BP and heart rate values were aver-
aged over each hour, over the day (from 0800 to 2000 h),
night (from 0100 to 0600 h) and over the entire 24-h
period [25]. The definition of daytime and night-time
based on narrow-fixed time interval was chosen because
of previous demonstrations of its better reproducibility
and relation with clinical outcomes, due to the exclusion
of transition periods during which a great between-yright © Lippincott Williams & Wilkins. Unauthparticipant variability in wakefulness and sleep times
occurs [26].
Study endpoints
The primary efficacy endpoint was the change in ambu-
latory mean 24-h systolic BP (SBP). Secondary endpoints
were changes in day-time or night-time BP, office BP,
antihypertensive treatment and QoL. The effects of inter-
vention on antihypertensive treatment were assessed by
considering both the number of participants on antihyper-
tensive treatment and the number of drugs assumed.
Statistical analysis
The predetermined sample size of groups was calculated
for providing at least 80% power (b) with P< 0.05 (a)
based on previous results with systolic home BP measure-
ments [14,19], taking a 5-mmHg difference in population
means with s¼ 5.5 mmHg [27]. Categorical variables
were compared with Fisher’s exact test. Statistical
analysis was conducted on derived variables given by
the difference between each measurement and the base-
line value within participant. A linear mixed-effect model
was fitted by Restricted Maximum Likelihood [28].
Random effects were specified for repeated measure-
ments within individual, whereas fixed effects were
specified for experimental conditions. A linear time trend
was also included in the model terms. A further model
was fitted allowing interaction terms between time and
experimental conditions. To explore variables affecting
intervention efficacy stepwise multivariate analysis
including age, sex, BMI, antihypertensive treatment
(expressed as both treated participants and class of drugs
assumed), and psychological subscales was preliminarily
performed. Variables selected were then inserted as
covariates in a generalized linear model to investigate
the effect of psychological subscales. The odds ratio (OR)
values of psychological subscale higher than the 75th
percentiles on a fixed arbitrary threshold of 24-h SBP (the
average reduction obtained at the 6-month follow-up)
were then calculated. A value of P< 0.05 was taken as the
minimum level of statistical significance throughout the
article. Statistical analysis was performed using the SPSS
(version 17.0; SPSS Inc., Chicago, Illinois, USA) and
STATA (StataCorp LP, Lakeway Drive, Texas, USA)
software packages.
Results
Patients population
Two patients in the Control-M group interrupted the
follow-up because of the diagnosis of neoplasia and were
excluded from data analysis. The therapist judged four
and three participants unable to correctly perform breath-
ing exercises at the end of the first and the second session,
respectively (baseline, 1-week). At the following sessions
(1, 3 and 6 months), all participants were found able to
correctly perform the requested procedure. Throughout
the follow-up period reported compliance with the studyorized reproduction of this article is prohibited.
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Changes of ambulatory systolic and diastolic blood pressure and heart rate at 6-month follow-up in the three groups of patients. In the intervention
group daily session of music-guided slow breathing exercises significantly reduced mean 24-h systolic blood pressure at 6-month follow-up
(P<0.001 at mixed model analysis).programme was comparable between groups. In particu-
lar, during all the study period patients assigned to the
treatment group on average performed 5.1 sessions/week
(out of the seven requested), for 22 min/day (out of
30 min requested). At 6-month follow-up the number
of weekly treatment sessions were significantly reduced
vs. baseline [mean reduction of 3.3 times/week, confi-
dence limits at 95% 2.3–4.4; P< 0.001 at analyses of
variance (ANOVA) test for repeated measurements].
Treatment efficacy
Blood pressure changes
In all participants the 24-h recordings were of good
technical quality. Statistical analysis conducted on the
difference between each ambulatory measurement and
the baseline value within participant revealed a signifi-opyright © Lippincott Williams & Wilkins. Unautho
Table 2 Mean changes (95% confidence limits) of mean ambulatory blo
(6-month visit) in controls and intervention groups
Variables Control-R (n¼31) Control-M (n¼24)
Systolic BP (mmHg)
Office 1.3 (3.2 to 1.8) 1.3 (3.6 to 2.1)
Mean 24-h 1.0 (2.2 to 1.2) 0.2 (1.9 to 2.0)
Daytime 1.0 (3.2 to 1.3) 0.6 (3.0 to 2.2)
Night-time 2.1 (3.2 to 1.0) 0.8 (1.7 to 3.0)
Diastolic BP (mmHg)
Office 0.8 (2.8 to 1.3) 1.4 (3.4 to 1.0)
Mean 24-h 1.5 (2.5 to 0.1) 0.6 (2.0 to 1.0)
Daytime 1.9 (3.3 to 0.0) 0.7 (2.7 to 0.9)
Night-time 1.1 (2.2 to 1.0) 0.2 (1.6 to 2.1)
Heart rate (bpm)
Office 0.6 (3.1 to 2.4) 0.5 (3.0 to 3.2)
Mean 24-h 1.2 (2.7 to 0.2) 1.5 (2.6 to 0.6)
Daytime 0.5 (2.5 to 0.8) 1.8 (2.8 to 1.0)
Night-time 1.6 (2.9 to 0.2) 0.8 (2.7 to 0.8)
BP, blood pressure.cant effect of intervention on SBP (Fig. 1 and Table 2). At
mixed model analysis, intervention was found to be
associated with a significant reduction of SBP values
measured in the office (P< 0.05) and at ambulatory
monitoring (mean 24-h, P¼ 0.001; night-time,
P< 0.0001) (Table 2). In particular, the intervention
group had on average a 24-h SBP 4.6 mmHg (95% con-
fidence limits 1.93–7.35) and 4.1 mmHg (95% confidence
limits 1.59–6.67) lower than that the Control-M and
Control-R groups, respectively (P< 0.001 for both)
(Table 2). It is worth nothing that the effect of interven-
tion on 24-h SBP was not significantly affected by time
(Chi-squared 1.68; 2 DF; P¼ 0.43). After the first follow-
up visit only a minor time-related further reduction was
indeed observed in the intervention group (0.1 mmHg/
month 95% confidence limits 0.2 to 0.01), whereas therized reproduction of this article is prohibited.
od pressure (mmHg), and heart rate (bpm) at the end of follow-up
P (mixed model)
Intervention (n¼29) Group (G) Time (T) GT
7.4 (7.9 to 2.6) 0.026 0.226 0.804
5.4 (6.4 to 2.8) 0.001 0.733 0.595
4.4 (6.2 to 1.3) 0.120 0.152 0.749
7.5 (8.7 to 4.3) <0.0001 0.015 0.809
3.9 (4.8 to 0.6) 0.373 0.622 0.854
2.9 (3.5 to 0.6) 0.301 0.628 0.807
3.1 (3.2 to 0.1) 0.775 0.379 0.414
4.3 (4.4 to 0.9) 0.062 0.073 0.867
0.6 (3.0 to 2.7) 0.973 0.411 0.840
1.3 (2.4 to 0.6) 0.942 0.492 0.630
1.0 (1.9 to 1.6) 0.825 0.126 0.414
0.9 (2.8 to 0.4) 0.940 0.751 0.656
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Table 3 Antihypertensive treatment (classes of drugs and participants on treatment) at baseline and at 6-month follow-up in controls and
intervention groups
P (mixed model)
Variables Control-R (n¼31) Control-M (n¼24) Intervention (n¼29) Group (G) GTime
Classes of drugs (mean [95% CL])
Baseline 1.8 (1.3–2.3) 1.8 (1.3–2.3) 1.5 (1.0–2.0)
6-month follow-up 1.9 (1.3–2.4) 1.9 (1.3–2.3) 1.4 (0.9–1.9) 0.486 0.910
Treated participants (n [%])
Baseline 26 (83.9%) 20 (83.3%) 21 (72.4%)
6-month follow-up 26 (83.9%) 21 (87.5%) 22 (75.9%) 0.295 0.509
CL, confidence limits.
Table 4 Multivariate stepwise regression analysis between
demographic, medical, psychological variables (Mental Health
Inventory subscales) and changes of mean 24-h systolic
ambulatory blood pressure at the 6-month visit
b (B; 95% CL) P
Antihypertensive treatmenta 0.679 (9.76; 5.09–14.43) <0.001
Number of drugs 0.169 0.486
Age 0.269 0.131
Sex (male) 0.105 0.521
BMI 0.015 0.930
Anxiety 0.137 0.394
Depression 0.124 0.454
Loss of behavioral and emotional control 0.065 0.688
General positive affect 0.142 0.383
Emotional ties 0.023 0.898
Satisfaction of life 0.084 0.612
Multiple r¼0.679. CL, confidence limits. a Selected at stepwise multiple
regression analysis.
Table 5 Effects of psychological subscales of Mental Health
Inventory and antihypertensive treatment on changes of mean 24-h
systolic blood pressure at 1week, 1, 3 and 6-month visits vs.
baseline
Generalized linear model
(TimeVariable)
Variables P Pa
Anxiety 0.229 0.154
Depression 0.498 0.152
Loss of behavioral and emotional control 0.176 0.035
General positive affect 0.041 0.001
Emotional ties 0.032 0.001
Satisfaction of life 0.225 0.070
Antihypertensive treatment – 0.003
a Antihypertensive treatment included in the model as covariate.other two groups remained stable (0.1 mmHg/month,
95% confidence limits 0.02–0.24; 0.05 mmHg/month
95% confidence limits 0.07 to 0.18 for groups M and
R, respectively). Between-group SBP differences were
not affected by covariate analysis that considered age,
BMI, medication status and sex. The 24-h diastolic BP
(DBP) changes displayed a similar trend of reduction but
did not reach statistical significance. The corresponding
heart rate changes did not show any time-related change
(Table 2).
Antihypertensive treatment
Antihypertensive treatment in the three groups was
comparable at baseline (Table 3). Mixed model analysis
did not reveal any significant effect of intervention on
antihypertensive treatment. In particular, no between-
group differences were observed in antihypertensive
treatment when either the number of drug classes
assumed per participant or the number of treated partici-
pants in each group was considered (Table 3).
Quality of life
At the 6-month visit no significant changes vs. basal
evaluation and no significant differences between groups
were observed on any multi-item dimensions analyzed in
the SF-36 questionnaire.
Exploring heterogeneity of efficacy within the
intervention group
Significant heterogeneity was observed in blood pressure
(BP) reduction in the intervention group. All participants
except one fulfilled psychological questionnaire at the
beginning of the study. Preliminary multivariate stepwise
analysis including age, sex, BMI, antihypertensive treat-
ment (expressed as both the number of participant on
antihypertensive treatment and the number of drugs
assumed) and psychological variables selected antihyper-
tensive treatment as the single significant negative
predictor of mean 24-h SBP reduction at the 6-month
follow-up (Table 4). In particular, average BP reduction
was 9.02 8.69 mmHg (95% confidence limits 16.29;
1.75) in untreated participants and 3.79 4.52 mmHg
(95% confidence limits 6.03;1.54) in participants who
were taking antihypertensive drugs. Antihypertensive
treatment was then inserted as covariate in a generalizedopyright © Lippincott Williams & Wilkins. Unauthlinear model to investigate the effect of psychological
subscales on changes of mean 24-h SBP at the 6-month
follow-up visit. Three psychological subscales were then
observed to affect the mean 24-h SBP reduction (general
positive affect P< 0.001; emotional ties, P< 0.001; loss of
behavioral control, P¼ 0.035) (Table 5).
In particular, when the average between-group difference
of mean 24-h SBP at the 6-month follow-up (4 mmHg)
was considered as the threshold value, level of general
positive affect higher than the 75th percentiles was found
to be significantly associated with low treatment efficacy
(OR 0.09; 95% CI 0.01–0.93; Fisher exact probability test,
P¼ 0.037) (Fig. 2).orized reproduction of this article is prohibited.
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Psychological subscales of Mental Health Inventory as predictors of
treatment efficacy. Odds ratio of reaching the average between-groups
difference of 24-h systolic blood pressure at the 6-month follow-up
(4 mmHg) for individuals belonging to the upper 75th percentiles of
the different psychological subscales. A level of general positive affect
higher than the 75th percentiles resulted to be significantly associated
with low treatment efficacy. CL, confidence level; OR, odds ratio.Blood pressure changes 6 months after interruption of
study protocol
Ambulatory BP monitoring performed 6 months after the
interruption of the study protocol in participants allocated
to the intervention group revealed that 24-h systolic BP
was still significantly reduced vs. baseline at multiple
comparison test (4.107 mmHg; 95% confidence limits
7.99 to0.22; P¼ 0.031). Likewise no significant differ-
ences were detected between mean 24-h SBP measured
6 months after the interruption of the study protocol
and values measured at 1-week (1.18 mmHg; 95% con-
fidence limits 5.07 to 2.70; P¼ 0.951), 1-month
(0.67 mmHg; 95% confidence limits 3.21 to 4.55;
P¼ 0.996), 3-month (1.39 mmHg; 95% confidence limits
2.49 to 5.27; P¼ 0.907) and at 6-month follow-up
(1.29 mmHg; 95% confidence limits 2.70 to 5.28;
P¼ 0.938).
Discussion
According to the present findings daily sessions of volun-
tary music-guided slow breathing significantly reduces
24-h systolic BP, and a psychological profile affecting the
antihypertensive response, can be identified.
The present study adopted the design of a randomized,
controlled clinical trial with some peculiarities. Blinding
of patients was mimicked by performing random
allocation leaving participants unaware of competitor
treatments thus limiting patient bias and personal expec-
tations. Likewise the physician treating BP was not aware
of group allocation and the therapist had no access to BP
data. Two control groups were also specifically included
because music, in addition to the known relaxing effect
[29,30], may exert a tempo entrainment on respiration
rate [19]. The lack of BP differences between the two
control groups, however, suggests that music alone (at
least at the tempo we selected) is not sufficient to give an
antihypertensive effect in clinical practice. Participants inopyright © Lippincott Williams & Wilkins. Unauthothe intervention group [5] listened to the same slow
music given to participants in the active control group
but were also taught respiration techniques. Thus, the
selective BP reduction in the intervention group
indicates voluntary breathing rate reduction as the active
component in relaxing treatments [31–35].
Inconsistency of results of studies investigating the anti-
hypertensive effects of different yoga procedures,
posture exercises, Jacobson’s method of progressive re-
laxation, autogenic training, simple meditation was
mainly attributed to methodological shortcomings (small
sample size, inconsistencies regarding baseline BP deter-
minations, types of control group, confounding by
multiple noncognitive cointerventions such as diet or
exercise) [5]. However, the possibility also exists that
some of the procedure used may have not reduced
breathing rate to less than 10 breath/min during the
exercise sessions. Although the value of this breathing
threshold is now recognized on the basis of clinical
studies [10–15], wherein daily sessions of device-guided
slow breathing reduced office and home BP at 2-month
follow-up, the present is the first study revealing that
music-guided voluntary slow breathing may induce a
significant reduction of 24-h ABP.
The mechanisms responsible for the BP reduction
induced by slow breathing are multifold and still poorly
understood. Certainly an important role is played by the
modulation of autonomic cardiovascular regulation,
characterized by an increased parasympathetic and a
reduced sympathetic activity, as documented by an
increase in the sensitivity of baroreflex heart rate modu-
lation during and after a paced slow breathing exercise
[7–9]. The present study was not designed to add infor-
mation regarding the mechanisms. However, the obser-
vation that the antihypertensive effect may persist
6 months after the interruption of exercise sessions might
suggest a possible persistent change of the reflex system.
We cannot exclude that participants allocated to the
intervention group may also have continued to perform
slow-breathing exercises during their usual daily routine
even if breathing rate measurements performed at follow-
up visits revealed no significant between-group differ-
ences.
Information regarding predictors of efficacy is especially
useful to move behavioral techniques into clinical prac-
tice. Probably due to the limited number of participants,
the role of psychological predictors was masked by anti-
hypertensive treatment, selected as the first-negative
independent predictors of efficacy. However, when anti-
hypertensive treatment is included in the model, the role
of psychological profile comes into view. More precisely,
the patients who appeared to benefit most from the
behavioral intervention reported high score on the ‘loss
of behavioral/emotional control’ scale and low ones on the
‘general positive affect’ and ‘emotional ties’ scale. On therized reproduction of this article is prohibited.
CBehavioral treatment and 24-h ABP Modesti et al. 1103whole, such patients showed symptoms of psychological
distress such as emotional instability, concern about
losing personal control, depressive thinking. Even the
psychological well-being appeared to be rather limited.
The patients manifested lack of self-confidence and
optimism, boredom, loneliness, unpleasant moods.
Therefore, psychological distress and social isolation
appeared to be positive psychological predictors of the
treatment efficacy. It may be worth noting that Green-
berg and Safran, [36] in their work on Emotion, found
several studies in which negative affect was positively
related to psychotherapy outcome.
The present study has different limitations. The sample
size is relatively small and therefore we could not adjust
for all potential confounders in the multivariable
regression models. We do not provide any insight regard-
ing the possible mechanism(s) linking behavioral pattern,
that is slow breathing, with the antihypertensive effect.
The sample used in the present study is quite hetero-
geneous and treated as well as nontreated hypertensive
patients were included. However, these aspects might
also represent the strength of the study reflecting ‘the real
world’ of consecutive, unselected hypertensive outpati-
ents seen in daily clinical practice.
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